ACR Appropriateness Criteria® Ovarian Cancer Screening

Pari V. Pandharipande, Kathryn P. Lowry, Caroline Reinhold, Mostafa Atri, Carol B. Benson, Priyadarshani R. Bhosale, Edward D. Green, Stella K. Kang, Yulia Lakhman, Katherine E. Maturen, Refky Nicola, Gloria M. Salazar, Thomas D. Shipp, Lynn Simpson, Betsy L. Sussman, Jennifer Uyeda, Darci J. Wall, Bradford Whitcomb, Carolyn M. Zelop, Phyllis GlancExpert Panel on Women's Imaging

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

There has been much interest in the identification of a successful ovarian cancer screening test, in particular, one that can detect ovarian cancer at an early stage and improve survival. We reviewed the currently available data from randomized and observational trials that examine the role of imaging for ovarian cancer screening in average-risk and high-risk women. We found insufficient evidence to recommend ovarian cancer screening, when considering the imaging modality (pelvic ultrasound) and population (average-risk postmenopausal women) for which there is the greatest available published evidence; randomized controlled trials have not demonstrated a mortality benefit in this setting. Screening high-risk women using pelvic ultrasound may be appropriate in some clinical situations; however, related data are limited because large, randomized trials have not been performed in this setting. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

Original languageEnglish (US)
Pages (from-to)S490-S499
JournalJournal of the American College of Radiology
Volume14
Issue number11
DOIs
StatePublished - Nov 1 2017

Fingerprint

Early Detection of Cancer
Ovarian Neoplasms
Guidelines
Expert Testimony
Radiology
Randomized Controlled Trials
Survival
Mortality
Therapeutics
Population

Keywords

  • Appropriate Use Criteria
  • Appropriateness Criteria
  • AUC
  • CA-125
  • Cancer screening
  • Ovarian cancer
  • Pelvic US

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Pandharipande, P. V., Lowry, K. P., Reinhold, C., Atri, M., Benson, C. B., Bhosale, P. R., ... Expert Panel on Women's Imaging (2017). ACR Appropriateness Criteria® Ovarian Cancer Screening. Journal of the American College of Radiology, 14(11), S490-S499. https://doi.org/10.1016/j.jacr.2017.08.049

ACR Appropriateness Criteria® Ovarian Cancer Screening. / Pandharipande, Pari V.; Lowry, Kathryn P.; Reinhold, Caroline; Atri, Mostafa; Benson, Carol B.; Bhosale, Priyadarshani R.; Green, Edward D.; Kang, Stella K.; Lakhman, Yulia; Maturen, Katherine E.; Nicola, Refky; Salazar, Gloria M.; Shipp, Thomas D.; Simpson, Lynn; Sussman, Betsy L.; Uyeda, Jennifer; Wall, Darci J.; Whitcomb, Bradford; Zelop, Carolyn M.; Glanc, Phyllis; Expert Panel on Women's Imaging.

In: Journal of the American College of Radiology, Vol. 14, No. 11, 01.11.2017, p. S490-S499.

Research output: Contribution to journalArticle

Pandharipande, PV, Lowry, KP, Reinhold, C, Atri, M, Benson, CB, Bhosale, PR, Green, ED, Kang, SK, Lakhman, Y, Maturen, KE, Nicola, R, Salazar, GM, Shipp, TD, Simpson, L, Sussman, BL, Uyeda, J, Wall, DJ, Whitcomb, B, Zelop, CM, Glanc, P & Expert Panel on Women's Imaging 2017, 'ACR Appropriateness Criteria® Ovarian Cancer Screening', Journal of the American College of Radiology, vol. 14, no. 11, pp. S490-S499. https://doi.org/10.1016/j.jacr.2017.08.049
Pandharipande PV, Lowry KP, Reinhold C, Atri M, Benson CB, Bhosale PR et al. ACR Appropriateness Criteria® Ovarian Cancer Screening. Journal of the American College of Radiology. 2017 Nov 1;14(11):S490-S499. https://doi.org/10.1016/j.jacr.2017.08.049
Pandharipande, Pari V. ; Lowry, Kathryn P. ; Reinhold, Caroline ; Atri, Mostafa ; Benson, Carol B. ; Bhosale, Priyadarshani R. ; Green, Edward D. ; Kang, Stella K. ; Lakhman, Yulia ; Maturen, Katherine E. ; Nicola, Refky ; Salazar, Gloria M. ; Shipp, Thomas D. ; Simpson, Lynn ; Sussman, Betsy L. ; Uyeda, Jennifer ; Wall, Darci J. ; Whitcomb, Bradford ; Zelop, Carolyn M. ; Glanc, Phyllis ; Expert Panel on Women's Imaging. / ACR Appropriateness Criteria® Ovarian Cancer Screening. In: Journal of the American College of Radiology. 2017 ; Vol. 14, No. 11. pp. S490-S499.
@article{c7a442b17cc1436fa2833219eea7e538,
title = "ACR Appropriateness Criteria{\circledR} Ovarian Cancer Screening",
abstract = "There has been much interest in the identification of a successful ovarian cancer screening test, in particular, one that can detect ovarian cancer at an early stage and improve survival. We reviewed the currently available data from randomized and observational trials that examine the role of imaging for ovarian cancer screening in average-risk and high-risk women. We found insufficient evidence to recommend ovarian cancer screening, when considering the imaging modality (pelvic ultrasound) and population (average-risk postmenopausal women) for which there is the greatest available published evidence; randomized controlled trials have not demonstrated a mortality benefit in this setting. Screening high-risk women using pelvic ultrasound may be appropriate in some clinical situations; however, related data are limited because large, randomized trials have not been performed in this setting. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.",
keywords = "Appropriate Use Criteria, Appropriateness Criteria, AUC, CA-125, Cancer screening, Ovarian cancer, Pelvic US",
author = "Pandharipande, {Pari V.} and Lowry, {Kathryn P.} and Caroline Reinhold and Mostafa Atri and Benson, {Carol B.} and Bhosale, {Priyadarshani R.} and Green, {Edward D.} and Kang, {Stella K.} and Yulia Lakhman and Maturen, {Katherine E.} and Refky Nicola and Salazar, {Gloria M.} and Shipp, {Thomas D.} and Lynn Simpson and Sussman, {Betsy L.} and Jennifer Uyeda and Wall, {Darci J.} and Bradford Whitcomb and Zelop, {Carolyn M.} and Phyllis Glanc and {Expert Panel on Women's Imaging}",
year = "2017",
month = "11",
day = "1",
doi = "10.1016/j.jacr.2017.08.049",
language = "English (US)",
volume = "14",
pages = "S490--S499",
journal = "JACR Journal of the American College of Radiology",
issn = "1558-349X",
publisher = "Elsevier BV",
number = "11",

}

TY - JOUR

T1 - ACR Appropriateness Criteria® Ovarian Cancer Screening

AU - Pandharipande, Pari V.

AU - Lowry, Kathryn P.

AU - Reinhold, Caroline

AU - Atri, Mostafa

AU - Benson, Carol B.

AU - Bhosale, Priyadarshani R.

AU - Green, Edward D.

AU - Kang, Stella K.

AU - Lakhman, Yulia

AU - Maturen, Katherine E.

AU - Nicola, Refky

AU - Salazar, Gloria M.

AU - Shipp, Thomas D.

AU - Simpson, Lynn

AU - Sussman, Betsy L.

AU - Uyeda, Jennifer

AU - Wall, Darci J.

AU - Whitcomb, Bradford

AU - Zelop, Carolyn M.

AU - Glanc, Phyllis

AU - Expert Panel on Women's Imaging

PY - 2017/11/1

Y1 - 2017/11/1

N2 - There has been much interest in the identification of a successful ovarian cancer screening test, in particular, one that can detect ovarian cancer at an early stage and improve survival. We reviewed the currently available data from randomized and observational trials that examine the role of imaging for ovarian cancer screening in average-risk and high-risk women. We found insufficient evidence to recommend ovarian cancer screening, when considering the imaging modality (pelvic ultrasound) and population (average-risk postmenopausal women) for which there is the greatest available published evidence; randomized controlled trials have not demonstrated a mortality benefit in this setting. Screening high-risk women using pelvic ultrasound may be appropriate in some clinical situations; however, related data are limited because large, randomized trials have not been performed in this setting. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

AB - There has been much interest in the identification of a successful ovarian cancer screening test, in particular, one that can detect ovarian cancer at an early stage and improve survival. We reviewed the currently available data from randomized and observational trials that examine the role of imaging for ovarian cancer screening in average-risk and high-risk women. We found insufficient evidence to recommend ovarian cancer screening, when considering the imaging modality (pelvic ultrasound) and population (average-risk postmenopausal women) for which there is the greatest available published evidence; randomized controlled trials have not demonstrated a mortality benefit in this setting. Screening high-risk women using pelvic ultrasound may be appropriate in some clinical situations; however, related data are limited because large, randomized trials have not been performed in this setting. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

KW - Appropriate Use Criteria

KW - Appropriateness Criteria

KW - AUC

KW - CA-125

KW - Cancer screening

KW - Ovarian cancer

KW - Pelvic US

UR - http://www.scopus.com/inward/record.url?scp=85032812008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032812008&partnerID=8YFLogxK

U2 - 10.1016/j.jacr.2017.08.049

DO - 10.1016/j.jacr.2017.08.049

M3 - Article

C2 - 29101987

AN - SCOPUS:85032812008

VL - 14

SP - S490-S499

JO - JACR Journal of the American College of Radiology

JF - JACR Journal of the American College of Radiology

SN - 1558-349X

IS - 11

ER -